Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 1 to 12 of 68 entries
Sorted by: Best Match Show Resources per page
Breast Reconstruction Using Contour Fenestrated AlloDerm: Does Improvement in Design Translate to Improved Outcomes?.

Plastic and reconstructive surgery. Global open

Frey JD, Alperovich M, Weichman KE, Wilson SC, Hazen A, Saadeh PB, Levine JP, Choi M, Karp NS.
PMID: 26495218
Plast Reconstr Surg Glob Open. 2015 Sep 04;3(9):e505. doi: 10.1097/GOX.0000000000000482. eCollection 2015 Sep.

BACKGROUND: Acellular dermal matrices are used in implant-based breast reconstruction. The introduction of contour fenestrated AlloDerm (Life-Cell, Branchburg, N.J.) offers sterile processing, a crescent shape, and prefabricated fenestrations. However, any evidence comparing reconstructive outcomes between this newer generation acellular...

Cite
Frey JD, Alperovich M, Weichman KE, et al. Breast Reconstruction Using Contour Fenestrated AlloDerm: Does Improvement in Design Translate to Improved Outcomes?. Plast Reconstr Surg Glob Open. 2015;3(9):e505doi: 10.1097/GOX.0000000000000482.
Frey, J. D., Alperovich, M., Weichman, K. E., Wilson, S. C., Hazen, A., Saadeh, P. B., Levine, J. P., Choi, M., & Karp, N. S. (2015). Breast Reconstruction Using Contour Fenestrated AlloDerm: Does Improvement in Design Translate to Improved Outcomes?. Plastic and reconstructive surgery. Global open, 3(9), e505. https://doi.org/10.1097/GOX.0000000000000482
Frey, Jordan D, et al. "Breast Reconstruction Using Contour Fenestrated AlloDerm: Does Improvement in Design Translate to Improved Outcomes?." Plastic and reconstructive surgery. Global open vol. 3,9 (2015): e505. doi: https://doi.org/10.1097/GOX.0000000000000482
Frey JD, Alperovich M, Weichman KE, Wilson SC, Hazen A, Saadeh PB, Levine JP, Choi M, Karp NS. Breast Reconstruction Using Contour Fenestrated AlloDerm: Does Improvement in Design Translate to Improved Outcomes?. Plast Reconstr Surg Glob Open. 2015 Sep 04;3(9):e505. doi: 10.1097/GOX.0000000000000482. eCollection 2015 Sep. PMID: 26495218; PMCID: PMC4596430.
Copy Download .nbib Format: NLM
Sleep, snoring and smoking in high school students.

Journal of sleep research

Delasnerie-Laupretre N, Patois E, Valatx JL, Kauffmann F, Alperovitch A.
PMID: 10607085
J Sleep Res. 1993 Sep;2(3):138-142. doi: 10.1111/j.1365-2869.1993.tb00077.x.

The relationship between snoring, sleep and smoking was investigated in young students from a survey by self-administered questionnaire on sleep habits, conducted in high schools in the educational district of Lyons (France). Our sample consisted of 11,417 boys and...

Cite
Delasnerie-Laupretre N, Patois E, Valatx JL, et al. Sleep, snoring and smoking in high school students. J Sleep Res. 1993;2(3):138-142doi: 10.1111/j.1365-2869.1993.tb00077.x.
Delasnerie-Laupretre, N., Patois, E., Valatx, J. L., Kauffmann, F., & Alperovitch, A. (1993). Sleep, snoring and smoking in high school students. Journal of sleep research, 2(3), 138-142. https://doi.org/10.1111/j.1365-2869.1993.tb00077.x
Delasnerie-Laupretre, et al. "Sleep, snoring and smoking in high school students." Journal of sleep research vol. 2,3 (1993): 138-142. doi: https://doi.org/10.1111/j.1365-2869.1993.tb00077.x
Delasnerie-Laupretre N, Patois E, Valatx JL, Kauffmann F, Alperovitch A. Sleep, snoring and smoking in high school students. J Sleep Res. 1993 Sep;2(3):138-142. doi: 10.1111/j.1365-2869.1993.tb00077.x. PMID: 10607085.
Copy Download .nbib Format: NLM
[Prevalence of asymptomatic atherothrombotic lesions and risk of vascular events in patients with documented coronary artery disease].

Archives des maladies du coeur et des vaisseaux

Collet JP, Allali Y, Borentain M, Payot L, Raoux F, Cacoub P, Leys D, Alperovitch A, Montalescot G.
PMID: 16294557
Arch Mal Coeur Vaiss. 2005 Oct;98:31-54.

Coronary arteries are the most frequent location of atherosclerosis. Coronary artery disease is the first cause of death related to atherothrombosis. In addition, patients with a prior history of acute coronary syndromes exhibit a 10% annual risk of recurrence....

Cite
Collet JP, Allali Y, Borentain M, et al. Prévalence des lésions athérothrombotiques asymptomatiques et risques d'evénements vasculaires chez des patients ayant une maladie coronaire documentée. [Prevalence of asymptomatic atherothrombotic lesions and risk of vascular events in patients with documented coronary artery disease]. Arch Mal Coeur Vaiss. 2005;98:31-54
Collet, J. P., Allali, Y., Borentain, M., Payot, L., Raoux, F., Cacoub, P., Leys, D., Alperovitch, A., Montalescot, G. (2005). Prévalence des lésions athérothrombotiques asymptomatiques et risques d'evénements vasculaires chez des patients ayant une maladie coronaire documentée. [Prevalence of asymptomatic atherothrombotic lesions and risk of vascular events in patients with documented coronary artery disease]. Archives des maladies du coeur et des vaisseaux, 9831-54.
Collet, J P, et al. "Prévalence des lésions athérothrombotiques asymptomatiques et risques d'evénements vasculaires chez des patients ayant une maladie coronaire documentée." [Prevalence of asymptomatic atherothrombotic lesions and risk of vascular events in patients with documented coronary artery disease]. Archives des maladies du coeur et des vaisseaux vol. 98 (2005): 31-54.
Collet JP, Allali Y, Borentain M, Payot L, Raoux F, Cacoub P, Leys D, Alperovitch A, Montalescot G. Prévalence des lésions athérothrombotiques asymptomatiques et risques d'evénements vasculaires chez des patients ayant une maladie coronaire documentée. [Prevalence of asymptomatic atherothrombotic lesions and risk of vascular events in patients with documented coronary artery disease]. Arch Mal Coeur Vaiss. 2005 Oct;98:31-54. French. PMID: 16294557.
Copy Download .nbib Format: NLM
Understanding the electronic structure of 4d metal complexes: from molecular spinors to L-edge spectra of a di-Ru catalyst.

Journal of the American Chemical Society

Alperovich I, Smolentsev G, Moonshiram D, Jurss JW, Concepcion JJ, Meyer TJ, Soldatov A, Pushkar Y.
PMID: 21866913
J Am Chem Soc. 2011 Oct 05;133(39):15786-94. doi: 10.1021/ja207409q. Epub 2011 Sep 13.

L(2,3)-edge X-ray absorption spectroscopy (XAS) has demonstrated unique capabilities for the analysis of the electronic structure of di-Ru complexes such as the blue dimer cis,cis-[Ru(III)(2)O(H(2)O)(2)(bpy)(4)](4+) water oxidation catalyst. Spectra of the blue dimer and the monomeric [Ru(NH(3))(6)](3+) model complex...

Cite
Alperovich I, Smolentsev G, Moonshiram D, et al. Understanding the electronic structure of 4d metal complexes: from molecular spinors to L-edge spectra of a di-Ru catalyst. J Am Chem Soc. 2011;133(39):15786-94doi: 10.1021/ja207409q.
Alperovich, I., Smolentsev, G., Moonshiram, D., Jurss, J. W., Concepcion, J. J., Meyer, T. J., Soldatov, A., & Pushkar, Y. (2011). Understanding the electronic structure of 4d metal complexes: from molecular spinors to L-edge spectra of a di-Ru catalyst. Journal of the American Chemical Society, 133(39), 15786-94. https://doi.org/10.1021/ja207409q
Alperovich, Igor, et al. "Understanding the electronic structure of 4d metal complexes: from molecular spinors to L-edge spectra of a di-Ru catalyst." Journal of the American Chemical Society vol. 133,39 (2011): 15786-94. doi: https://doi.org/10.1021/ja207409q
Alperovich I, Smolentsev G, Moonshiram D, Jurss JW, Concepcion JJ, Meyer TJ, Soldatov A, Pushkar Y. Understanding the electronic structure of 4d metal complexes: from molecular spinors to L-edge spectra of a di-Ru catalyst. J Am Chem Soc. 2011 Oct 05;133(39):15786-94. doi: 10.1021/ja207409q. Epub 2011 Sep 13. PMID: 21866913.
Copy Download .nbib Format: NLM
Spectroscopic analysis of catalytic water oxidation by [Ru(II)(bpy)(tpy)H2O]2+ suggests that Ru(V)═O is not a rate-limiting intermediate.

Journal of the American Chemical Society

Pushkar Y, Moonshiram D, Purohit V, Yan L, Alperovich I.
PMID: 25130482
J Am Chem Soc. 2014 Aug 27;136(34):11938-45. doi: 10.1021/ja506586b. Epub 2014 Aug 18.

Modern chemistry's grand challenge is to significantly improve catalysts for water splitting. Further progress requires detailed spectroscopic and computational characterization of catalytic mechanisms. We analyzed one of the most studied homogeneous single-site Ru catalysts, [Ru(II)(bpy)(tpy)H2O](2+) (where bpy = 2,2'-bipyridine,...

Cite
Pushkar Y, Moonshiram D, Purohit V, et al. Spectroscopic analysis of catalytic water oxidation by [Ru(II)(bpy)(tpy)H2O]2+ suggests that Ru(V)═O is not a rate-limiting intermediate. J Am Chem Soc. 2014;136(34):11938-45doi: 10.1021/ja506586b.
Pushkar, Y., Moonshiram, D., Purohit, V., Yan, L., & Alperovich, I. (2014). Spectroscopic analysis of catalytic water oxidation by [Ru(II)(bpy)(tpy)H2O]2+ suggests that Ru(V)═O is not a rate-limiting intermediate. Journal of the American Chemical Society, 136(34), 11938-45. https://doi.org/10.1021/ja506586b
Pushkar, Yulia, et al. "Spectroscopic analysis of catalytic water oxidation by [Ru(II)(bpy)(tpy)H2O]2+ suggests that Ru(V)═O is not a rate-limiting intermediate." Journal of the American Chemical Society vol. 136,34 (2014): 11938-45. doi: https://doi.org/10.1021/ja506586b
Pushkar Y, Moonshiram D, Purohit V, Yan L, Alperovich I. Spectroscopic analysis of catalytic water oxidation by [Ru(II)(bpy)(tpy)H2O]2+ suggests that Ru(V)═O is not a rate-limiting intermediate. J Am Chem Soc. 2014 Aug 27;136(34):11938-45. doi: 10.1021/ja506586b. Epub 2014 Aug 18. PMID: 25130482.
Copy Download .nbib Format: NLM
A Predictive Model for Determining Permanent Implant Size During 2-Stage Implant Breast Reconstruction.

Plastic and reconstructive surgery. Global open

Gabrick KS, Markov NP, Chouairi F, Wu R, Persing SM, Abraham P, Avraham T, Alperovich M.
PMID: 29922567
Plast Reconstr Surg Glob Open. 2018 May 21;6(5):e1790. doi: 10.1097/GOX.0000000000001790. eCollection 2018 May.

BACKGROUND: Two-stage tissue expander (TE)/permanent implant (PI) breast reconstruction remains the most commonly performed technique in breast reconstruction. Predictions for the PI size preoperatively impact on the number and range of implants made available at TE exchange. This study...

Cite
Gabrick KS, Markov NP, Chouairi F, et al. A Predictive Model for Determining Permanent Implant Size During 2-Stage Implant Breast Reconstruction. Plast Reconstr Surg Glob Open. 2018;6(5):e1790doi: 10.1097/GOX.0000000000001790.
Gabrick, K. S., Markov, N. P., Chouairi, F., Wu, R., Persing, S. M., Abraham, P., Avraham, T., & Alperovich, M. (2018). A Predictive Model for Determining Permanent Implant Size During 2-Stage Implant Breast Reconstruction. Plastic and reconstructive surgery. Global open, 6(5), e1790. https://doi.org/10.1097/GOX.0000000000001790
Gabrick, Kyle S, et al. "A Predictive Model for Determining Permanent Implant Size During 2-Stage Implant Breast Reconstruction." Plastic and reconstructive surgery. Global open vol. 6,5 (2018): e1790. doi: https://doi.org/10.1097/GOX.0000000000001790
Gabrick KS, Markov NP, Chouairi F, Wu R, Persing SM, Abraham P, Avraham T, Alperovich M. A Predictive Model for Determining Permanent Implant Size During 2-Stage Implant Breast Reconstruction. Plast Reconstr Surg Glob Open. 2018 May 21;6(5):e1790. doi: 10.1097/GOX.0000000000001790. eCollection 2018 May. PMID: 29922567; PMCID: PMC5999420.
Copy Download .nbib Format: NLM
Predictors for Prolonged Drain Use Following Autologous Breast Reconstruction.

Journal of reconstructive microsurgery

Dinis J, Allam O, Junn A, Park KE, Mozaffari MA, Shah R, Avraham T, Alperovich M.
PMID: 34284504
J Reconstr Microsurg. 2021 Jul 20; doi: 10.1055/s-0041-1731765. Epub 2021 Jul 20.

BACKGROUND:  Surgical drains are routinely used following autologous reconstruction, but are often cited as the leading cause of peri-operative discomfort. This study defined routine drain use duration and assessed the risk factors for prolonged breast and abdominal drain use...

Cite
Dinis J, Allam O, Junn A, et al. Predictors for Prolonged Drain Use Following Autologous Breast Reconstruction. J Reconstr Microsurg. 2021;doi: 10.1055/s-0041-1731765.
Dinis, J., Allam, O., Junn, A., Park, K. E., Mozaffari, M. A., Shah, R., Avraham, T., & Alperovich, M. (2021). Predictors for Prolonged Drain Use Following Autologous Breast Reconstruction. Journal of reconstructive microsurgery, . https://doi.org/10.1055/s-0041-1731765
Dinis, Jacob, et al. "Predictors for Prolonged Drain Use Following Autologous Breast Reconstruction." Journal of reconstructive microsurgery vol. (2021). doi: https://doi.org/10.1055/s-0041-1731765
Dinis J, Allam O, Junn A, Park KE, Mozaffari MA, Shah R, Avraham T, Alperovich M. Predictors for Prolonged Drain Use Following Autologous Breast Reconstruction. J Reconstr Microsurg. 2021 Jul 20; doi: 10.1055/s-0041-1731765. Epub 2021 Jul 20. PMID: 34284504.
Copy Download .nbib Format: NLM
Long-term efficacy and safety of risankizumab for the treatment of moderate-to-severe plaque psoriasis: interim analysis of the LIMMitless open-label extension trial beyond 3 years of follow-up.

The British journal of dermatology

Papp KA, Lebwohl MG, Puig L, Ohtsuki M, Beissert S, Zeng J, Rubant S, Sinvhal R, Zhao Y, Soliman AM, Alperovich G, Leonardi C.
PMID: 34157132
Br J Dermatol. 2021 Jun 22; doi: 10.1111/bjd.20595. Epub 2021 Jun 22.

BACKGROUND: Psoriasis is a chronic inflammatory skin disease requiring prolonged treatment. New biologic therapies require long-term evaluation to assess the durability of their efficacy and safety profiles over time.OBJECTIVES: To evaluate the long-term efficacy and safety of risankizumab (RZB)...

Cite
Papp KA, Lebwohl MG, Puig L, et al. Long-term efficacy and safety of risankizumab for the treatment of moderate-to-severe plaque psoriasis: interim analysis of the LIMMitless open-label extension trial beyond 3 years of follow-up. Br J Dermatol. 2021;doi: 10.1111/bjd.20595.
Papp, K. A., Lebwohl, M. G., Puig, L., Ohtsuki, M., Beissert, S., Zeng, J., Rubant, S., Sinvhal, R., Zhao, Y., Soliman, A. M., Alperovich, G., & Leonardi, C. (2021). Long-term efficacy and safety of risankizumab for the treatment of moderate-to-severe plaque psoriasis: interim analysis of the LIMMitless open-label extension trial beyond 3 years of follow-up. The British journal of dermatology, . https://doi.org/10.1111/bjd.20595
Papp, K A, et al. "Long-term efficacy and safety of risankizumab for the treatment of moderate-to-severe plaque psoriasis: interim analysis of the LIMMitless open-label extension trial beyond 3 years of follow-up." The British journal of dermatology vol. (2021). doi: https://doi.org/10.1111/bjd.20595
Papp KA, Lebwohl MG, Puig L, Ohtsuki M, Beissert S, Zeng J, Rubant S, Sinvhal R, Zhao Y, Soliman AM, Alperovich G, Leonardi C. Long-term efficacy and safety of risankizumab for the treatment of moderate-to-severe plaque psoriasis: interim analysis of the LIMMitless open-label extension trial beyond 3 years of follow-up. Br J Dermatol. 2021 Jun 22; doi: 10.1111/bjd.20595. Epub 2021 Jun 22. PMID: 34157132.
Copy Download .nbib Format: NLM
"Validation of Artificial Intelligence Severity Assessment in Metopic Craniosynostosis".

The Cleft palate-craniofacial journal : official publication of the American Cleft Palate-Craniofacial Association

Junn A, Dinis J, Hauc SC, Bruce MK, Park KE, Tao W, Christensen C, Whitaker R, Goldstein JA, Alperovich M.
PMID: 34787505
Cleft Palate Craniofac J. 2021 Nov 17;10556656211061021. doi: 10.1177/10556656211061021. Epub 2021 Nov 17.

OBJECTIVE: Several severity metrics have been developed for metopic craniosynostosis, including a recent machine learning-derived algorithm. This study assessed the diagnostic concordance between machine learning and previously published severity indices.DESIGN: Preoperative computed tomography (CT) scans of patients who underwent...

Cite
Junn A, Dinis J, Hauc SC, et al. "Validation of Artificial Intelligence Severity Assessment in Metopic Craniosynostosis". Cleft Palate Craniofac J. 2021;10556656211061021doi: 10.1177/10556656211061021.
Junn, A., Dinis, J., Hauc, S. C., Bruce, M. K., Park, K. E., Tao, W., Christensen, C., Whitaker, R., Goldstein, J. A., & Alperovich, M. (2021). "Validation of Artificial Intelligence Severity Assessment in Metopic Craniosynostosis". The Cleft palate-craniofacial journal : official publication of the American Cleft Palate-Craniofacial Association, 10556656211061021. https://doi.org/10.1177/10556656211061021
Junn, Alexandra, et al. ""Validation of Artificial Intelligence Severity Assessment in Metopic Craniosynostosis"." The Cleft palate-craniofacial journal : official publication of the American Cleft Palate-Craniofacial Association vol. (2021): 10556656211061021. doi: https://doi.org/10.1177/10556656211061021
Junn A, Dinis J, Hauc SC, Bruce MK, Park KE, Tao W, Christensen C, Whitaker R, Goldstein JA, Alperovich M. "Validation of Artificial Intelligence Severity Assessment in Metopic Craniosynostosis". Cleft Palate Craniofac J. 2021 Nov 17;10556656211061021. doi: 10.1177/10556656211061021. Epub 2021 Nov 17. PMID: 34787505.
Copy Download .nbib Format: NLM
A Comparison of BREAST-Q Scores between Prepectoral and Subpectoral Direct-to-Implant Breast Reconstruction.

Plastic and reconstructive surgery

Le NK, Persing S, Dinis J, Gabrick KS, Wu RT, Sinnott CJ, Avraham T, Young AO, Alperovich M.
PMID: 34705769
Plast Reconstr Surg. 2021 Nov 01;148(5):708e-714e. doi: 10.1097/PRS.0000000000008410.

BACKGROUND: Subpectoral breast implant placement has in recent history predominated in breast reconstruction, but there has been more recent adoption of prepectoral implant reconstruction. There has been limited study to date of patient-reported outcomes comparing the two techniques.METHODS: Patients...

Cite
Le NK, Persing S, Dinis J, et al. A Comparison of BREAST-Q Scores between Prepectoral and Subpectoral Direct-to-Implant Breast Reconstruction. Plast Reconstr Surg. 2021;148(5):708e-714edoi: 10.1097/PRS.0000000000008410.
Le, N. K., Persing, S., Dinis, J., Gabrick, K. S., Wu, R. T., Sinnott, C. J., Avraham, T., Young, A. O., & Alperovich, M. (2021). A Comparison of BREAST-Q Scores between Prepectoral and Subpectoral Direct-to-Implant Breast Reconstruction. Plastic and reconstructive surgery, 148(5), 708e-714e. https://doi.org/10.1097/PRS.0000000000008410
Le, Nicole K, et al. "A Comparison of BREAST-Q Scores between Prepectoral and Subpectoral Direct-to-Implant Breast Reconstruction." Plastic and reconstructive surgery vol. 148,5 (2021): 708e-714e. doi: https://doi.org/10.1097/PRS.0000000000008410
Le NK, Persing S, Dinis J, Gabrick KS, Wu RT, Sinnott CJ, Avraham T, Young AO, Alperovich M. A Comparison of BREAST-Q Scores between Prepectoral and Subpectoral Direct-to-Implant Breast Reconstruction. Plast Reconstr Surg. 2021 Nov 01;148(5):708e-714e. doi: 10.1097/PRS.0000000000008410. PMID: 34705769.
Copy Download .nbib Format: NLM
Long-term efficacy and safety of risankizumab for the treatment of moderate-to-severe plaque psoriasis: interim analysis of the LIMMitless open-label extension trial beyond 3 years of follow-up.

The British journal of dermatology

Papp KA, Lebwohl MG, Puig L, Ohtsuki M, Beissert S, Zeng J, Rubant S, Sinvhal R, Zhao Y, Soliman AM, Alperovich G, Leonardi C.
PMID: 34157132
Br J Dermatol. 2021 Dec;185(6):1135-1145. doi: 10.1111/bjd.20595. Epub 2021 Sep 21.

BACKGROUND: Psoriasis is a chronic inflammatory skin disease requiring prolonged treatment. New biologic therapies require long-term evaluation to assess the durability of their efficacy and safety profiles over time.OBJECTIVES: To evaluate the long-term efficacy and safety of risankizumab (RZB)...

Cite
Papp KA, Lebwohl MG, Puig L, et al. Long-term efficacy and safety of risankizumab for the treatment of moderate-to-severe plaque psoriasis: interim analysis of the LIMMitless open-label extension trial beyond 3 years of follow-up. Br J Dermatol. 2021;185(6):1135-1145doi: 10.1111/bjd.20595.
Papp, K. A., Lebwohl, M. G., Puig, L., Ohtsuki, M., Beissert, S., Zeng, J., Rubant, S., Sinvhal, R., Zhao, Y., Soliman, A. M., Alperovich, G., & Leonardi, C. (2021). Long-term efficacy and safety of risankizumab for the treatment of moderate-to-severe plaque psoriasis: interim analysis of the LIMMitless open-label extension trial beyond 3 years of follow-up. The British journal of dermatology, 185(6), 1135-1145. https://doi.org/10.1111/bjd.20595
Papp, K A, et al. "Long-term efficacy and safety of risankizumab for the treatment of moderate-to-severe plaque psoriasis: interim analysis of the LIMMitless open-label extension trial beyond 3 years of follow-up." The British journal of dermatology vol. 185,6 (2021): 1135-1145. doi: https://doi.org/10.1111/bjd.20595
Papp KA, Lebwohl MG, Puig L, Ohtsuki M, Beissert S, Zeng J, Rubant S, Sinvhal R, Zhao Y, Soliman AM, Alperovich G, Leonardi C. Long-term efficacy and safety of risankizumab for the treatment of moderate-to-severe plaque psoriasis: interim analysis of the LIMMitless open-label extension trial beyond 3 years of follow-up. Br J Dermatol. 2021 Dec;185(6):1135-1145. doi: 10.1111/bjd.20595. Epub 2021 Sep 21. PMID: 34157132.
Copy Download .nbib Format: NLM
The Efficacy of Virtual Subinternships as a Novel Educational Platform for Education and Recruitment.

Plastic and reconstructive surgery

Dinis J, Prsic A, Junn A, Hsia H, Alperovich M.
PMID: 34495920
Plast Reconstr Surg. 2021 Oct 01;148(4):691e-693e. doi: 10.1097/PRS.0000000000008364.

No abstract available.

Cite
Dinis J, Prsic A, Junn A, et al. The Efficacy of Virtual Subinternships as a Novel Educational Platform for Education and Recruitment. Plast Reconstr Surg. 2021;148(4):691e-693edoi: 10.1097/PRS.0000000000008364.
Dinis, J., Prsic, A., Junn, A., Hsia, H., & Alperovich, M. (2021). The Efficacy of Virtual Subinternships as a Novel Educational Platform for Education and Recruitment. Plastic and reconstructive surgery, 148(4), 691e-693e. https://doi.org/10.1097/PRS.0000000000008364
Dinis, Jacob, et al. "The Efficacy of Virtual Subinternships as a Novel Educational Platform for Education and Recruitment." Plastic and reconstructive surgery vol. 148,4 (2021): 691e-693e. doi: https://doi.org/10.1097/PRS.0000000000008364
Dinis J, Prsic A, Junn A, Hsia H, Alperovich M. The Efficacy of Virtual Subinternships as a Novel Educational Platform for Education and Recruitment. Plast Reconstr Surg. 2021 Oct 01;148(4):691e-693e. doi: 10.1097/PRS.0000000000008364. PMID: 34495920; PMCID: PMC8452240.
Copy Download .nbib Format: NLM
Showing 1 to 12 of 68 entries